DRIO DARIOHEALTH CORP Capital Structure Changes 8-K Filing 2024 - Preferred Stock Changes DarioHealth Corp. amended its Series B-3 Preferred Stock terms, extending the mandatory conversion period from 15 to 18 months and increasing dividends to 10% for the fifth quarter and 25% for the sixth quarter.Get access to all SEC 8-K filings of the DARIOHEALTH CORP